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Abnormalities during brain development are thought
to cause psychiatric illness and other neurodevelop-
mental disorders. However, developmental pro-
cesses such as neurogenesis continue in restricted
brain regions of adults, and disruptions of these
processes could contribute to the phenotypes of
neurodevelopmental disorders. As previously re-
ported, we show that Disc1 knockdown specifically
in adult-born dentate gyrus (DG) neurons results in
increased mTOR signaling, hyperexcitability, and
neuronal structure deficits.Disc1 knockdown also re-
sulted in pronounced cognitive and affective deficits,
which could be reversed when the affected DG
neurons were inactivated. Importantly, reversing
increases in mTOR signaling with an FDA-approved
inhibitor both prevented and treated these behavioral
deficits, even when associated structural deficits
were not reversed. Our findings suggest that
a component of the affective and cognitive pheno-
types in neurodevelopmental disorders may be
caused by disruptions in adult-born neurons. Conse-
quently, treatments directed at this cell population
may have a significant impact on these phenotypes.
INTRODUCTION
Neurodevelopmental disorders have long been thought to be
caused by irreversible changes during development (Ehningeret al., 2008b). However, developmental processes, such as
neuronal progenitor cell proliferation, migration, and differentia-
tion, continue throughout life in defined brain cell populations,
such as adult-born dentate gyrus (DG) neurons. These neurons
are functionally integrated into existing circuitry and, impor-
tantly, there is evidence suggesting that they are involved in
learning and memory and other behaviors (Arruda-Carvalho
et al., 2011; Deng et al., 2009; Mao et al., 2009). Thus, besides
affecting prenatal and postnatal development, gene mutations
(e.g., in Disc1 or Disrupted-in-schizophrenia 1) responsible for
neurodevelopmental disorders could also affect adult-born
neurons and therefore disrupt learning and memory and other
behaviors.
The Disc1 gene was originally discovered in a large Scottish
family with a high incidence of psychiatric illness, including
schizophrenia, bipolar disorder, and depression (St Clair et al.,
1990). Disc1’s expression pattern, its role in proliferation and
cell migration, as well as its interacting proteins all demonstrate
an important role for this gene in neuronal development (Austin
et al., 2004; Camargo et al., 2007; Ishizuka et al., 2011). Several
animal models with Disc1 mutations during development re-
ported altered brainmorphology, abnormal plasticity, and cogni-
tive and affective deficits (Clapcote et al., 2007; Hikida et al.,
2007; Kvajo et al., 2008; Li et al., 2007).
Our studies of DISC1 function in adult-born DG neurons
provide evidence that disruption of processes that modulate
adult neurogenesis could play an important role in the cognitive
and affective deficits associated with neurodevelopmental
disorders. Our results also challenge the widely held view that
reversing neuronal structural deficits associated with neurode-
velopmental disorders is critical for reversing associated behav-
ioral phenotypes.Neuron 77, 647–654, February 20, 2013 ª2013 Elsevier Inc. 647
Figure 1. Effects of Disc1 Knockdown on Cognitive and Affective
Behaviors
(A) Representative images of adult-born DG neurons infected with shRNA-
Cont or shRNA-DISC1 virus (blue, DAPI; green, GFP, imaged 3 weeks after
virus injection). Scale bar represents 20 mm. (B) Total number of GFP+ neurons
in DG. (C) The percentage of exploration time during the object-place recog-
nition test at 24 hr after training (shRNA-Cont n = 8, shRNA-DISC1 n = 7;
*p < 0.05, one-sample t test compared to 50%). (D) The percent of exploration
time during the novel object recognition test at 24 hr after training (shRNA-Cont
n = 8, shRNA-DISC1 n = 7; *p < 0.05, **p < 0.01, one-sample t test compared to
50%). (E) In the forced swim test, the immobility time of shRNA-DISC1 mice
(n = 7) was significantly higher than shRNA-Cont mice (n = 8; *p < 0.05, t test).
(F) In the elevated plus maze test, shRNA-DISC1 mice spent a lower
percentage of time in the open arms of the plus maze than shRNA-Cont mice
(shRNA-Cont n = 7, shRNA-DISC1 n = 7; *p < 0.05, t test). All data are shown as
means ± SEM.
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Disc1 Knockdown in Adult-Born Neurons Results
in Cognitive and Affective Phenotypes
To disrupt DISC1 function specifically in DG newborn neurons
in the adult mouse brain, we used a validated oncoretrovirus
approach (Duan et al., 2007; Kim et al., 2009). To infect prolif-
erating neural progenitors in vivo, we stereotaxically injected
DISC1 (shRNA-DISC1) or control (shRNA-Cont) retrovirus,
which only infects proliferating neural progenitors, instead of
postmitotic DG cells, into the hilar region of hippocampus.
Previous studies using the same shRNA-DISC1 retrovirus
showed specific and effective knockdown of Disc1 levels,
and Disc1 knockdown caused aberrant dendritic morphology
and mispositioning of adult-born dentate granule cells (Duan
et al., 2007), as well as abnormal axonal targeting (Faulkner
et al., 2008).648 Neuron 77, 647–654, February 20, 2013 ª2013 Elsevier Inc.We confirmed that Disc1 knockdown causes abnormal devel-
opment of adult-born DG neurons, including mispositioning of
these neurons, dendritic structural abnormalities with multiple
primary dendrites, and severe axon targeting defects of DISC1-
downregulated adult-born neurons (Figure 1A and see Figures
S1A–S1D available online). Since the retroviruses included a GFP
marker, we were able to count the number of DG cells infected
with these viruses. Three weeks after retrovirus infection, there
were approximately 500 GFP+ neurons in the DG of mice infected
with either the shRNA-Cont or shRNA-DISC1 viruses (Figure 1B).
Cognitive deficits are commonly associated with neurodeve-
lopmental disorders (Ehninger et al., 2008b). To test whether
Disc1 knockdown in adult-born DG neurons affected cognitive
function, mice were tested in the object-place recognition task,
a hippocampal-dependent test (Oliveira et al., 2010). Disc1
knockdown in adult-born neurons causes profound deficits
during the object-place recognition test: while control mice
spent significantly more time exploring the object at the new
location, the shRNA-DISC1 mice did not (Figure 1C).
Interestingly, the shRNA-DISC1 mice did not show deficits in
novel object recognition (NOR), a nonhippocampal-dependent
task (Oliveira et al., 2010) that shares many of the same motiva-
tional and visual-perceptual demands with the object-place
task. During the NOR test at 24 hr after training, both shRNA-Cont
mice and shRNA-DISC1mice spentmore time exploring the novel
object (Figure 1D). In agreement with the idea that Disc1 knock-
down in adult-born neurons causes deficits in hippocampal-
dependent learning, shRNA-DISC1 mice showed deficits in the
hidden platform version of the water maze (see Figure S2B).
Changes in adult newborn DG neurons have been associated
with affective phenotypes, including anxiety and depression (San-
tarelli et al., 2003; Snyder et al., 2011). These phenotypes are also
common in neurodevelopmental disorders. For example, depres-
sion and other affective phenotypes were found to be widespread
in a family segregating a chromosomal translocation that disrup-
ted the Disc1 locus (St Clair et al., 1990). The immobility time dur-
ing the forced-swim test has been used to assess depression-like
behaviors in rodents (Mao et al., 2009; Strekalova et al., 2004).
During the forced swim test, shRNA-DISC1mice showed a signif-
icant increase in immobility time as compared to shRNA-Cont
mice (Figure 1E), suggesting that the disruption of DISC1 function
in DG adult-born neurons causes depression-like phenotypes. To
determine whether Disc1 knockdown also leads to abnormalities
in another affective behavior common in neurodevelopmental
disorders (i.e., anxiety) (Rinehart et al., 2002; Tsiouris and Brown,
2004), we tested mice in the elevated plus maze. shRNA-DISC1
mice spent a lower percentage of time in the open arms than
shRNA-Cont mice (Figure 1F), suggesting that Disc1 knockdown
in adult-born DG neurons results in increased anxiety.
Considering the neuroanatomically and developmentally
restricted nature of the DISC1 manipulation studied here, it is
not surprising that the shRNA-DISC1 mice did not recapitulate
all of the phenotypes previously observed in more global Disc1
disruptions in mice (Clapcote et al., 2007; Mao et al., 2009).
For example, the shRNA-DISC1 mice did not show deficits in
the open field activity test (Figure S4A).
To test whether the behavioral deficits of the shRNA-DISC1
mice were caused by the knockdown of Disc1 specifically in
Figure 2. Inactivation of Adult-Born Neurons Expressing Disc1
shRNA Reverses Deficits in the Elevated Plus Maze and Object-
Place Recognition
(A) A diagram of the retroviral vector expressing control or Disc1 shRNA and
hemagglutinin (HA)-tagged allatostatin receptor (AlstR). (B) Representative
images of AlstR expression (blue, DAPI; red, HA, imaged 3 weeks after virus
injection). Scale bar represents 20 mm. (C) In the elevated plus maze test, al-
latostatin (10 mM) was infused into the dentate gyrus at 30 min before the test.
DISC1/veh mice (n = 10) spent a lower percentage of time in the open arms of
the plus maze than mice in the other three groups (Cont/veh n = 11, Cont/Alst
n = 8, DISC1/Alst n = 9; *p < 0.05, **p < 0.01, planed t test). (D) In the object-
place recognition task, allatostatin was infused into the dentate gyrus at
30 min before both training and testing. With the exception of the DISC1/veh
mice (n = 10), mice from the other three groups (Cont/veh n = 11, Cont/Alst
n = 6, DISC1/Alst n = 9) spent significantlymore time exploring the object at the
new location (*p < 0.05, one-sample t test compared to 50%). All data are
shown as means ± SEM.
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Disc1 KD in Adult-Born Neurons Causes Deficitsthe dentate gyrus, control or shRNA-DISC1 virus was injected to
CA1, another hippocampal region that is known to play an impor-
tant role in learning andmemory. shRNA-DISC1 virus injection to
CA1 did not cause any behavioral changes in all of the tasks
tested, including the open field, elevated plus maze, forced
swim, and object-place recognition tests (Figures S3A–S3D).
Additionally, no GFP+ neurons were observed in CA1 at 3 weeks
after virus injection (data not shown).
Inactivation of Adult-Born Neurons Expressing Disc1
shRNA Reverses Specific Behavioral Phenotypes
To directly test whether DISC1-deficient adult-born neurons in
DG are the cause of the cognitive and affective phenotypes
observed in shRNA-DISC1 mice, we used the allatostatin
receptor system (Tan et al., 2006; Zhou et al., 2009) to inactivate
these neurons prior to testing. Retroviruses coexpressing the
allatostatin receptor as well as control (shRNA-Cont-Alst) or
Disc1 shRNA (shRNA-DISC1-Alst) were injected into the dentate
gyrus (Figures 2A and 2B).
Two weeks after virus injection, mice were tested in the
elevated plus maze test. The DGs of these mice were infused
with allatostatin 30min before testing. Consistent with the results
presented above, shRNA-DISC1-Alst mice with vehicle infusion
into the DG (DISC1/veh group) spent less time in the open armsas compared to shRNA-Cont-Alst mice treated with vehicle
(Cont/veh; Figure 2C, Cont/Veh versus DISC1/Veh, p < 0.05).
Allatostatin inactivation of adult-born neurons with the shRNA-
DISC1-Alst virus significantly increased the time mice spent in
the open arms (Figure 2C, DISC1/Alst versus DISC1/Veh,
p < 0.01).
Approximately 3 weeks after virus injection, mice were tested
in the object-place recognition task. Infected adult-born neurons
were inactivated with DG allatostatin infusions 30 min before
both training and testing. The shRNA-Cont-Alst mice infused
with either vehicle (cont/Veh) or allatostatin (cont/Alst) performed
normally: they spent more time exploring the object at the new
location (Figure 2D). shRNA-DISC1-Alst mice infused with
vehicle (DISC1/Veh) spent a similar percentage of time exploring
the object at the new location compared to the old location (i.e.,
showed learning and memory deficits). In contrast, shRNA-
DISC1-Alst mice treated with allatostatin (DISC1/Alst) spent
significantly more time exploring the object at the new location
(Figure 2D). Taken together, these results demonstrate that the
adult-born neurons with DISC1 knockdown are responsible for
the affective (elevated plus maze) and cognitive (object-place
recognition) deficits described here.
Rapamycin Treatment Prevents Morphogenesis,
Excitability, and Specific Behavioral Deficits Resulting
from Disc1 Knockdown
Rapamycin, an FDA-approved compound that inhibits mTOR,
has been shown to prevent the morphogenesis deficits caused
by Disc1 knockdown in adult-born DG neurons when neuronal
morphology was examined 1 day after the last rapamycin treat-
ment (Kim et al., 2009). Our analyses show that rapamycin treat-
ment prevented the increase in the number of primary dendrites
of adult-born neurons infected with shRNA-DISC1 (Fig-
ure 3B; two-way ANOVA, [shRNA virus3 treatment] interaction:
F(1,10) = 34.41; post hoc linear contrast: DISC1/veh versus
DISC1/rap, t(10) = 8.23, p < 0.001) and ameliorated the misposi-
tioning of adult-born DG neurons (Figure 3C). In our study, mice
were treated with rapamycin (20 mg/kg, intraperitoneally [i.p.]) at
5, 7, 9, 11, and 13 days after retroviral injection, and neuronal
morphology was examined 4 weeks after the last rapamycin
treatment (Figure 3A). Thus, our results demonstrated that the
effects of the rapamycin treatment last at least 4 weeks.
To test the effect of rapamycin on the increased excitability re-
ported for adult-born DG neurons with Disc1 knockdown (Duan
et al., 2007), we treated mice with rapamycin at 5, 7, 9, 11, and
13 days, and we recorded the excitability of GFP+ neurons at
14 days after retroviral injection (Figure 3D). As before, quantifi-
cation of the number of action potentials shows that Disc1
knockdown resulted in enhanced excitability. Additionally, our
findings showed that rapamycin treatment prevented this
enhanced excitability (Figure 3E; two-way ANOVA, [shRNA
virus 3 treatment] interaction: F(1,19) = 5.23; post hoc linear
contrast: Cont/veh versus DISC1/veh, t(19) = 3.80, p < 0.01;
DISC1/veh versus DISC1/rap, t(19) = 3.30, p < 0.01).
Importantly, the same rapamycin treatment could also prevent
the memory deficits in the object-place recognition test.
Although shRNA-DISC1 mice treated with vehicle (DISC1/veh
group) spent the same percentage of time exploring the objectNeuron 77, 647–654, February 20, 2013 ª2013 Elsevier Inc. 649
Figure 3. Effects of Rapamycin Treatment
on the Morphogenesis and Excitability of
Adult-Born Neurons and on Behavioral Defi-
cits Caused by Disc1 Knockdown
(A) Diagram of rapamycin treatment for mor-
phology examination. (B) Compared to control
neurons, the adult-born neurons with Disc1
knockdown have increased number of primary
dendrites that are prevented by rapamycin treat-
ment (***p < 0.001, two-way ANOVA). Numbers
associated with bar graph indicate the number of
neurons examined from at least three mice from
each group. (C) Positioning of adult-born neurons
in DG. Layer 1, layer 2, and layer 3 refer to the
inner, the middle, and the outer layers of granule
cells in DG, respectively; layer 4 refers to the
molecular layer. (D) Sample traces recorded from
GFP+ neurons in response to 800 ms, 100 pA
current injection before and after the addition of
TTX (1 mM) at 14 days after virus injection. Scale
bar represents 50 mV and 200 ms. (E) Quantifica-
tion of the total number of action potentials with
800 ms stimulation (Con/veh, Cont/rap and
DISC1/veh: n = 5, DISC1/rap n = 8; **p < 0.01, two-
way ANOVA). (F) The percentage of exploration
time during the object-place recognition test at
24 hr after training. Cont/veh and DISC1/rap mice
spent significantly more time exploring the object
at the new location (Con/veh n = 14, Cont/rap n =
12, DISC1/veh n = 14, DISC1/rap n = 15; ***p <
0.001, one-sample t test compared to 50%). (G) In
the forced swim test, the immobile time of
DISC1/veh mice (n = 11) was significantly higher
than Cont/veh mice (n = 12), and this increased
immobility was prevented by rapamycin treatment
(DISC1/rap n = 9). Two-way ANOVA, *p < 0.05,
***p < 0.001. (H) DISC1/veh mice spent a lower
percentage of time in the open arms of the plus
maze than Cont/veh mice (Cont/veh n = 16,
DISC1/veh n = 17; *p < 0.05). There was no
significant difference between DISC1/rap and
Cont/rap (DISC1/rap n = 15, Cont/rap n = 13,
p > 0.05, two-way ANOVA). All data are shown as
means ± SEM.
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group and Cont/veh group spent significantly more time
exploring the object at the new location (Figure 3F). During
training, mice from all groups spent a similar time exploring the
two objects (Figure S4B), indicating that the deficits are not
caused by changes in exploratory behavior. Remarkably, the
Cont/rap group spent a similar percentage of time exploring
the object at the new location compared to the old location,
demonstrating that the rapamycin treatment that prevented the
learning deficits in the shRNA-DISC1 mice caused learning defi-
cits in the control mice.650 Neuron 77, 647–654, February 20, 2013 ª2013 Elsevier Inc.Rapamycin improved the performance
of the shRNA-DISC1 mice in the forced
swim test: although the DISC1/veh group
showed a significant increase in immo-
bility as compared to Cont/veh group,
the immobility time of DISC1/rap groupwas decreased when compared to that of DISC1/veh group (Fig-
ure 3G; two-way ANOVA, [treatment3 shRNA virus] interaction:
F(1,37) = 2.134; post hoc linear contrast: Cont/veh versusDISC1/
veh, t(37) = 2.37, p < 0.05; DISC1/rap versus DISC1/veh, t(37) =
4.90, p < 0.001). Interestingly, the Cont/rap group (n = 9) also
showed decreased immobility compared to the Cont/veh group
(Figure 3G; post hoc linear contrast: Cont/veh versus Cont/rap,
t(37) = 2.91, p < 0.01), a result consistent with previous reports
that rapamycin has antidepressant effects (Cleary et al., 2008).
Rapamycin also improved the performance of the shRNA-
DISC1 mice in the elevated plus maze. Although the DISC1/veh
Neuron
Disc1 KD in Adult-Born Neurons Causes Deficitsgroup spent significantly less time in the open arms when
compared with Cont/veh group (Figure 3H; two-way ANOVA,
overall [treatment 3 shRNA virus] interaction: F(1,57) = 1.46;
main effect of shRNA virus: F(1,57) = 4.68, post hoc linear
contrast: Cont/veh versus DISC1/veh, t(57) = 2.49, p < 0.05),
the time spent in the open arms by the DISC1/rap, Cont/rap,
and Cont/veh groups were indistinguishable. In contrast to the
object-place recognition test, rapamycin did not seem to prevent
the spatial learning deficits in the water maze (Figure S2D).
Late Rapamycin Treatment Rescues Abnormal
Signaling and Specific Behavioral Deficits without
Reversing Structural Abnormalities
Two-week-old adult-born DG neurons with Disc1 knockdown
show aberrant dendritic morphology, mispositioning, and hyper-
activation of mTOR signaling pathway (Kim et al., 2009). We next
tested whether treatment of mTOR signaling deficits, specifically
started at 2 weeks postinjection when structural deficits are
already present, ameliorate the behavioral phenotypes.
We confirmed that 2 weeks after virus injection, Disc1 knock-
down causes aberrant dendritic morphology and mispositioning
of adult-born dentate granule cells (Figures S4E and S4F). We
next determined whether rapamycin treatment (i.p. injection,
20mg/kg) initiated at 14 days postinjection (dpi), and given every
other day from day 14 to day 26 (henceforth referred to as late [L]
rapamycin treatment), reversed the dendritic morphogenesis
and mispositioning examined on day 28 (Figure 4A). Compared
to adult-born neurons in the shRNA-Cont (Cont/veh-L or
Cont/rap-L) groups, those in the shRNA-DISC1 (DISC1/veh-L
or DISC1/rap-L) groups still showed increased number of
primary dendrites (Figure 4B; two-way ANOVA, [shRNA virus 3
treatment] interaction: F(1,15) = 1.622; main effect of shRNA
virus: F(1,15) = 183.2, p < 0.001 between shRNA-cont and
shRNA-DISC1). There was no difference between DISC1/veh
and DISC1/rap groups in mispositioning scores (Figure 4C), indi-
cating that the late rapamycin treatment did not rescue the
morphological abnormalities caused by Disc1 knockdown.
To determine whether the late rapamycin treatment had an
impact on mTOR signaling in these neurons, we tested the
phosphorylation (i.e., activation) of an mTOR substrate (S6).
Importantly, the increase we found in S6 phosphorylation was
completely reversed by late rapamycin treatment (Figures 4D
and 4E). This result shows that although late rapamycin treat-
ment failed to rescue the morphological deficits, it rescued the
abnormal mTOR signaling of adult-born neurons with a Disc1
knockdown.
We next testedwhether the rescue ofmTOR signalingwith late
rapamycin treatment could reverse learning andmemory deficits
in the object-place test. For this experiment, rapamycin was in-
jected every other day from day 14 to day 22 and also 3 hr before
training in object-place recognition (at 26 dpi). One day after
training, the Cont/veh-L and DISC1/rap-L groups, but not
DISC1/veh-L or Cont/rap-L groups, spent significantly more
time exploring the object at the new location (Figure 4F), demon-
strating that rapamycin treatment that causes deficits in controls
rescues the learning deficits of shRNA-DISC1 mice. During
training, mice from all groups spent similar time exploring the
two objects (Figure S4C).Late rapamycin treatment also has an impact on the affective
phenotype of shRNA-DISC1 mice. Mice were injected with
rapamycin every other day from day 14 to day 20 after virus
injection, as well as 3 hr before the forced swim test on day 22.
The DISC1/veh-L group showed longer immobility time
than Cont/veh-L group. In contrast, the performance of the
DISC1/rap-L group was indistinguishable from that of the
Cont/rap-L or Cont/veh-L groups (Figure 4G; two-way ANOVA,
[treatment 3 shRNA virus] interaction: F(1,50) = 7.364, p <
0.01; post hoc linear contrast: Cont/veh-L versus DISC1/veh-L,
t(50) = 3.12, p < 0.01; DISC1/rap-L versus DISC1/veh-L,
t(50) = 4.68, p < 0.001), indicating that the depression-like
behavior can also be rescued with late rapamycin treatment.
We also tested whether an acute injection of rapamycin 3 hr
before testing (14 days after virus injection) in the elevated plus
maze could rescue the anxiety phenotype of shRNA-DISC1
mice. As before, DISC1/veh group spent a lower percentage of
time in the open arms when compared to the Cont/veh group.
However, the performance of DISC1/rap and Cont/rap groups
was indistinguishable (Figure 4H; two-way ANOVA, overall
[treatment3 shRNA virus] interaction: F(1,47) = 2.46; main effect
of shRNA virus: F(1,47) = 4.26, p < 0.05, post hoc linear contrast:
Cont/veh versus DISC1/veh, t(47) = 2.59, p < 0.05). Additionally,
there were no statistically significant differences between the
performances of Cont/veh, DISC1/rap, and Cont/rap groups
(Figure 4H).
We showed that knockdownofDisc1 in adult-bornDGneurons
results in enhanced excitability measured 14 days after retroviral
injection. However, when the excitability of GFP+ neurons was
measured at 26 days after retroviral injection (Figure 4I), there
was no significant difference between these two groups (Fig-
ure 4J, p > 0.05, Student’s t test), indicating that by day 26 the
shRNA-Cont neurons had similar excitability as shRNA-DISC1
neurons. This result also demonstrates that increased excitability
could not be the cause of the behavioral deficits of shRNA-DISC1
mice measured 26 days after retroviral injection.
DISCUSSION
In this study, we found that disruption of DISC1 function only
in z500 adult-born DG neurons is sufficient to cause several
profound behavioral phenotypes, including pronounced learning
andmemory deficits, aswell as clear anxiety and depression-like
phenotypes. These results suggest that an important component
of the behavioral phenotypes common in neurodevelopmental
disorders, such as those caused by Disc1 mutations, could be
due to disruptions of developmental-like processes associated
with adult-born DG neurons. Our studies demonstrated that
the knockdown of Disc1 leads to increases in mTOR signaling
in the targeted newborn DG neurons and indicated that this
signaling abnormality is responsible for the cognitive and affec-
tive deficits. Indeed, an FDA-approved drug that decreases
mTOR signaling reversed these behavioral deficits even when
associated neuroanatomical abnormalities persisted. These
results offer new hope to themany individuals affected by neuro-
developmental disorders, since it demonstrates the feasibility of
adult rescue of profound behavioral phenotypes associated with
this class of disorders.Neuron 77, 647–654, February 20, 2013 ª2013 Elsevier Inc. 651
Figure 4. Effects of Late Rapamycin Treat-
ment on the Morphogenesis, Phosphory-
lated S6 Levels, and Behavioral Deficits
Caused by Disc1 Knockdown
(A) Diagram of the late rapamycin treatment. (B)
Compared to control adult-born neurons, the
neurons with Disc1 knockdown had significantly
higher number of primary dendrites (two-way
ANOVA, ***p < 0.001 between shRNA-cont and
shRNA-DISC1; numbers in the bar graph indicate
the number of neurons examined in each group
from at least four mice). (C) Positioning of adult-
born neurons in DG. Layers were defined in
Figure 3C. (D) Sample confocal images of im-
munostainining for GFP, phosphorylated S6 (pS6),
and DAPI. Scale bar represents 20 mm. (E) Quan-
tifications of pS6 levels in the cytosol of GFP+
neurons. The pS6 fluorescence intensity of indi-
vidual GFP+ neuron was first normalized to that of
the neighboring granule cells in the same image.
Numbers in the bar graph indicate the number of
neurons examined in eachgroup fromat least three
mice (*p < 0.05, one-way ANOVA). (F) During the
object-place recognition test, Cont/veh mice
(n = 11; *p < 0.05, one-sample t test compared to
50%) and DISC1/rap mice (n = 10; **p < 0.01, one-
sample t test compared to 50%) significantly spent
more time exploring the object at the new location,
while the DISC1/veh mice (n = 10) and Cont/rap
mice (n = 10) did not. (G) Effect of late rapamycin
treatment on forced swim. The immobility time of
DISC1/veh mice (n = 13) was significantly higher
than Cont/veh mice (n = 15; **p < 0.01), and this
increased immobility was reversed by rapamycin
treatment (DISC1/rap n = 13; ***p < 0.001, two-way
ANOVA). (H) In the elevated plus maze test,
compared to Cont/veh mice, DISC1/veh mice
spent a lower percentage of time in the open arms
of the plus maze (Cont/veh n = 14; DISC1/veh n =
12; *p < 0.05, two-way ANOVA). There was no
significant difference between DISC1/rap and
Cont/rap (DISC1/rap n = 13, Cont/rap n = 12; p >
0.05). (I) Sample traces recorded from GFP+
neurons in response to 800 ms, 100 pA current
injection at 26 days after virus injection. Scale bar
represents 50 mV and 200 ms. (J) Quantification of
the total number of action potentials with 800 ms
stimulation (shRNA-con n = 8, shRNA-DISC1
n = 10). All data are shown as means ± SEM.
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Disc1 KD in Adult-Born Neurons Causes DeficitsPrevious results that we confirmed here indicated that
knocking down Disc1 in adult newborn DG neurons results in
increases in mTOR signaling, enhanced excitability, aberrant
dendritic structure, abnormal axonal targeting, and misposi-
tioning of adult-born dentate granule cells. Studies that specif-
ically inactivated the Disc1 knockdown neurons with the
allatostatin receptor system allowed us to demonstrate that
the behavioral phenotypes described are caused by these652 Neuron 77, 647–654, February 20, 2013 ª2013 Elsevier Inc.neurons, since their inactivation reversed
key cognitive and affective phenotypes.
A knockdown of the Disc1 gene specif-
ically and exclusively in adult-born DGneurons resulted in pronounced deficits in two hippocampal-
dependent tasks, the object-place recognition task and the
spatial version of the Morris water maze. Interestingly, perfor-
mance in the novel object recognition task, which can be solved
with nonhippocampal strategies, appeared to be unaffected by
the Disc1 knockdown. This result attests to the hippocampal
specificity of the learning andmemory deficits. Aswith the cogni-
tive phenotypes of the shRNA-DISC1 mice, their affective
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Disc1 KD in Adult-Born Neurons Causes Deficitsphenotypes were also specific. For example, a dentate gyrus
Disc1 knockdown that was not specific to newborn neurons re-
sulted in open field hyperactivity (Mao et al., 2009). In contrast,
our newborn neuron-specific knockdown of Disc1 in DG did
not affect performance in the open field task. The difference
between the results of these two studies is likely due to the differ-
ence in the neuronal specificities of the tools used.
Here, we show that rapamycin treatment reverses key
behavioral deficits of shRNA-DISC1 mice. However, the exact
mechanism of rapamycin rescue is still unclear. Remarkably,
the rapamycin treatment, which rescued memory deficits in the
object-place recognition test in the shRNA-DISC1 mice, caused
memory deficits in control mice. mTOR signaling has been
shown to play an important role in synaptic protein translation
and long-term plasticity (Tang et al., 2002), as well as in long-
term memory consolidation and reconsolidation (Stoica
et al., 2011). Therefore, it is not surprising that the multiday
rapamycin treatment impairs memory in control mice. Addition-
ally, increased mTOR signaling has been associated with
pronounced cognitive and affective deficits in mouse models
of neurodevelopmental disorders (Ehninger et al., 2008a). Alto-
gether, our results demonstrate that the increase in mTOR
signaling observed in newborn DG neurons with Disc1 knock-
down is a key contributor to the behavioral deficits of shRNA-
DISC1 mice.
Recently, animal model studies suggested that treating the
molecular deficits underlying neurodevelopmental disorders
could result in significant amelioration of associated behavioral
phenotypes, even when treatments were initiated in adults
(Ehninger et al., 2008b). This suggests that the complex behav-
ioral phenotypes associated with neurodevelopmental disorders
have developmental (e.g., abnormal circuitry) and adult (e.g.,
abnormal signaling and plasticity) components and that treat-
ment of one of these two components may be sufficient to result
in significant improvements in overall function. Remarkably, our
late rapamycin treatment studies show that significant improve-
ment in behavioral deficits can be obtained even when structural
and morphological deficits are not reversed.
Our results also demonstrate the importance and specificity of
the involvement of adult-born DG neurons in both cognitive and
affective behaviors. It is important to note that our shRNA-DISC1
manipulation did not block adult neurogenesis. Instead, it
dramatically altered the neuroanatomical and neurophysiolog-
ical properties of a subset of adult-born DG neurons. In contrast
to previous studies that used approaches to block neurogenesis,
we show that altering the signaling, morphology, and physiology
of even a very small subset of these neurons can have profound
effects on multiple cognitive and affective behaviors.
In summary, the studies reported here provide evidence for
the hypothesis that a key component of the behavioral deficits
associated with neurodevelopmental disorders, such as those
associated with Disc1mutations, could be caused by disruption
of development-like processes involved in the generation and
maturation of newborn DG neurons in adults. Furthermore, we
show that a key component of these behavioral deficits can be
reversed by adult treatments that target signaling deficits, even
when associated structural and morphological deficits are not
reversed. Understanding adult mechanisms contributing toneurodevelopmental disorders may lead to the development
of treatments for millions of adults affected with this class of
disorders.
EXPERIMENTAL PROCEDURES
Mouse Behavior
In the elevated plus maze test, mice were allowed to explore an elevated plus
maze for 5 min. The elevated plus maze has two open arms and two closed
arms (with walls of 16.5 cm height), and each arm is 29 cm long and 8 cm
wide. The percentage of time mice spent in the open arms was analyzed.
During the forced swim test, mice were placed in an 18-cm-diameter cylin-
drical container filled with water (20 cm height) at 25C. The behavior of the
mice was recorded for 5 min and the total immobility time of each mouse
was measured. In the object-place recognition and novel object recognition
tasks, mice were trained in the experimental box for 10 min and mice were
put back into the same box for the recognition test at 24 hr after training.
For complete details of the recognition test, please see the Supplemental
Experimental Procedures.
Immunostaining
Micewere transcardially perfusedwith 4%PFA (4%paraformaldehyte in 0.1M
phosphate buffer) and after perfusion, brains were sliced coronally (50 mm
thick) with vibratome and processed for immunostaining. Primary antibodies,
including rabbit anti-GFP (Abcam, 1:500), rabbit anti-pS6 (Cell Signaling,
1:200), andmouse anti-BrdU (Invitrogen, 1:500) were used for immunostaining.
Brain slices were incubated with 4’,6-diaminodino-2-phenylindole (DAPI,
Invitrogen, 1:2,000) for 15 min before mounting onto slides. Immunostaining
images were acquired with an Olympus FluoView 1000 Laser Scanning Con-
focal Microscope (LSCM), and 700 nm femtosecond pulses from Ti:Saphire
(Mai Tai, Spectra Physics) were used for two-photon excitation of DAPI.
Electrophysiology
The whole-cell patch-clamp configuration was employed in the current-clamp
mode with current pulses (100 pA, 800 ms) injected. Microelectrodes (4–6MU)
were filled with the internal solution containing 120 mM potassium gluconate,
15 mMKCl, 4 mMMgCl2, 0.1 mM EGTA, 10.0 mMHEPES, 4 mMATP (magne-
sium salt), 0.3 mMGTP (sodium salt), and 7 mM phosphocreatine (pH 7.4, 300
mOsm). Series and input resistances were monitored, and only those with
changes less than 20% during experiments were analyzed. For complete
details please see the Supplemental Experimental Procedures.
Statistical Analysis
Results are expressed as mean ± SEM. ANOVA analyses or Student’s t tests
were used for statistical comparisons between groups as described in the
Results or figure legends. p < 0.05 indicates significant difference between
groups.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2012.12.033.
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